|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.8900 - 0.9400|
|52 Week Range||0.6550 - 5.3300|
|Beta (3Y Monthly)||2.85|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Cannabis brand Binske announced Monday it has partnered with the multistate operator MariMed Inc (OTC: MRMD) in a licensing deal. Binske products are presently found in Colorado, Nevada, California and Florida. Under the deal, products will become available in Ohio, Maryland, Illinois, Massachusetts, Rhode Island, Delaware and Maine.
While cannabis wasn’t really a hot topic in the Democratic presidential debate last week, it was trending in the news after Illinois Gov. J. B. Pritzker printed his autograph on the legalization bill, making the state the 11th to legalize adult-use marijuana. “The bill also includes a ‘social equity program,’ which makes it easier for those with marijuana convictions to get business licenses and the program also allocates $12 million for startup businesses related to cannabis,” she said. Another bill that would provide protections to banks that service legal cannabis businesses was passed in the House and is now in Senators’ hands.
The Land of Lincoln could soon be the land of legal recreational marijuana -- and these three stocks should be winners as a result.
Investors and major cannabis execs were in the same room April 17-18 at Benzinga's Cannabis Capital Conference in Toronto. Cannabis has the "power to transform human and wellness," said Robert Fireman, president and CEO of Marimed Inc (OTC: MRMD). One of the ways the medical cannabis company makes its mark is by offering a pure CBD product to treat children suffering from epilepsy, he said.
Marimed Inc (OTCMKTS:MRMD), a major US. hemp and cannabis operator, announced on Thursday that it plans to buy 70% of MediTaurus stake and the transaction will be handled by its MariMed Hemp subsidiary. MediTaurus holds numerous intellectual property patents for cannabis formulations and it also owns the Florance CBD health brand. The latter has a […]The post Marimed To Purchase 70% Of MediTaurus appeared first on Market Exclusive.
He was once a proud prohibitionist, often referring to cannabis as a gateway drug. But after Cynthia Nixon gave New York Gov. Andrew Cuomo a run for his money during the primaries, Cuomo quickly realized ...
From companies going public on major exchanges, mergers and acquisitions and full legalization of weed in Canada, 2018 was a transformational year in cannabis. One major milestone for the industry was the passage of the 2018 Farm Bill. The legalization of hemp and its removal from Schedule I of the Controlled Substances Act is viewed as a major step forward for the cannabis industry because it legalizes hemp-derived cannabidiol, or CBD.
As the United States waits for president Trump to sign the 2018 Farm Bill before next year, cannabis operator Marimed Inc (OTCMKTS:MRMD) has made an official announcement concerning a significant investment in hemp. The statement has hailed the passing of the Bill and its becoming law soon as this is considered the official inauguration of […] The post Marimed Expects To Lead In Hemp Derived CBD Following 2018 Farm Bill Passage appeared first on Market Exclusive.
The cannabis industry is quickly turning into a multi-billion dollar powerhouse thanks to the drastic demand for cannabis products. Reports have it that cannabis revenues are likely to hit $9 billion by the end of the year. This kind of speculation has resulted in serious investment by various companies seeking to grab a share of […] The post Demand For Cannabis Prompts Marimed To Expand CBD Hemp Operations appeared first on Market Exclusive.
When medical cannabis became legal in Maryland last year, New Frontier Data projected 2018 sales would come in at around $46 million. When compared to other states with high median incomes, such as Hawaii, California and Massachusetts, Maryland remains a fairly inexpensive state in which to live. Marijuana is still only medically legal in Maryland, and it’s already on pace to bring in $1 million in its first year.
As the industry impatiently awaits passage of the 2018 Farm Bill and pending removal of hemp from the Controlled Substances Act, companies are quickly moving to position themselves as leading suppliers of hemp-based CBD products, and investors are all too happy to help foot the bill. Two companies that have been particularly aggressive in their pursuit of the hemp-based CBD market have been Elixinol Global Ltd. (OTCQX: ELLXF) and MariMed, Inc. (OTCQB:MRMD). Shares for the IPO were sold at $1.00 AUD per share ($0.73 USD), but the stock quickly climbed to $1.82 AUD ($1.32 USD) within the first week of trading.
When the market is volatile, investors flee to safety. Often, investors will retreat out of growth names and into more established industries. We saw that trend play out in October on the over-the-counter ...